Literature DB >> 20072141

Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population.

M Tang1, Y Zeng, A Poisson, D Marti, L Guan, Y Zheng, H Deng, J Liao, X Guo, S Sun, G Nelson, G de Thé, C A Winkler, S J O'Brien, M Carrington, X Gao.   

Abstract

We have conducted a comprehensive case-control study of a nasopharyngeal carcinoma (NPC) population cohort from Guangxi Province of Southern China, a region with one of the highest NPC incidences on record. A total of 1407 individuals including NPC patients, healthy controls, and their adult children were examined for the human leukocyte antigen (HLA) association, which is so far the largest NPC cohort reported for such studies. Stratified analysis performed in this study clearly demonstrated that while NPC protection is associated with independent HLA alleles, most NPC susceptibility is strictly associated with HLA haplotypes. Our study also detected for the first time that A(*)0206, a unique A2 subtype to South and Southeast Asia is also associated with a high risk for NPC. HLA-A(*)0206, HLA-B(*)3802 alleles plus the A(*)0207-B(*)4601 and A(*)3303-B(*)5801 haplotypes conferred high risk for NPC showing a combined odds ratio (OR) of 2.6 (P<0.0001). HLA alleles that associate with low risk for NPC include HLA-A(*)1101, B(*)27, and B(*)55 with a combined OR of 0.42 (P<0.0001). The overall high frequency of NPC-susceptible HLA factors in the Guangxi population is likely to have contributed to the high-NPC incidence in this region.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072141      PMCID: PMC3737777          DOI: 10.1038/gene.2009.109

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  29 in total

1.  Association between microsatellites within the human MHC and nasopharyngeal carcinoma.

Authors:  E E Ooi; E C Ren; S H Chan
Journal:  Int J Cancer       Date:  1997-04-22       Impact factor: 7.396

2.  Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study.

Authors:  D Jeannel; A Hubert; F de Vathaire; R Ellouz; M Camoun; M Ben Salem; H Sancho-Garnier; G de-Thé
Journal:  Int J Cancer       Date:  1990-09-15       Impact factor: 7.396

3.  Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region.

Authors:  S J Lu; N E Day; L Degos; V Lepage; P C Wang; S H Chan; M Simons; B McKnight; D Easton; Y Zeng
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

4.  Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States.

Authors:  R D Burt; T L Vaughan; B McKnight; S Davis; A M Beckmann; A G Smith; B Nisperos; G M Swanson; M Berwick
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-11       Impact factor: 4.254

5.  Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients.

Authors:  L V Johansen; M Mestre; J Overgaard
Journal:  Head Neck       Date:  1992 May-Jun       Impact factor: 3.147

6.  Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China.

Authors:  M C Yu; T B Huang; B E Henderson
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

7.  Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China.

Authors:  M C Yu; D H Garabrant; T B Huang; B E Henderson
Journal:  Int J Cancer       Date:  1990-06-15       Impact factor: 7.396

8.  Nasopharyngeal carcinoma in Saudi Arabia: a retrospective study of 166 cases treated with curative intent.

Authors:  G E Laramore; B Clubb; C Quick; M H Amer; M Ali; W Greer; E Mahboubi; M el-Senoussi; H Schultz; S M el-Akkad
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-11       Impact factor: 7.038

9.  Familial aggregation of nasopharyngeal carcinoma and other malignancies. A clinicopathologic description.

Authors:  C M Coffin; S S Rich; L P Dehner
Journal:  Cancer       Date:  1991-09-15       Impact factor: 6.860

10.  Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan.

Authors:  S B Wu; S J Hwang; A S Chang; T Hsieh; M M Hsu; R P Hsieh; C J Chen
Journal:  Anticancer Res       Date:  1989 Nov-Dec       Impact factor: 2.480

View more
  17 in total

Review 1.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

Review 2.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

Review 3.  The molecular march of primary and recurrent nasopharyngeal carcinoma.

Authors:  Nicholas J Campion; Munira Ally; Bernhard J Jank; Jahangir Ahmed; Ghassan Alusi
Journal:  Oncogene       Date:  2021-01-21       Impact factor: 9.867

4.  Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma.

Authors:  Yong Zheng; Greg Parsonage; Xiaodong Zhuang; Lee R Machado; Christine H James; Asmaa Salman; Peter F Searle; Edwin P Hui; Anthony T C Chan; Steven P Lee
Journal:  Cancer Immunol Res       Date:  2015-02-24       Impact factor: 11.151

5.  HLA-A*02-B*46 haplotype: an adverse prognostic factor in Han patients with nasopharyngeal carcinoma.

Authors:  Ruo-Zheng Wang; Dian-Gang Zhang; Ran Wu; Yun-Hui Hu; Yan-Chun Peng; Cheng Chang; Tao Dong; Xi-Yan Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

6.  Further evidence for the existence of major susceptibility of nasopharyngeal carcinoma in the region near HLA-A locus in Southern Chinese.

Authors:  Manli Zhao; Hongbing Cai; Xin Li; Hang Zheng; Xuexi Yang; Weiyi Fang; Longcheng Zhang; Ganguan Wei; Ming Li; Kaitai Yao; Xin Li
Journal:  J Transl Med       Date:  2012-03-22       Impact factor: 5.531

7.  The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.

Authors:  Vivaldo G da Costa; Ariany C Marques-Silva; Marcos L Moreli
Journal:  Syst Rev       Date:  2015-04-13

8.  Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma.

Authors:  Wan-Lun Hsu; Ka-Po Tse; Sharon Liang; Yin-Chu Chien; Wen-Hui Su; Kelly J Yu; Yu-Juen Cheng; Ngan-Ming Tsang; Mow-Ming Hsu; Kai-Ping Chang; I-How Chen; Tzu-I Chen; Czau-Siung Yang; Alisa M Goldstein; Chien-Jen Chen; Yu-Sun Chang; Allan Hildesheim
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

9.  The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.

Authors:  Minzhong Tang; James A Lautenberger; Xiaojiang Gao; Efe Sezgin; Sher L Hendrickson; Jennifer L Troyer; Victor A David; Li Guan; Carl E McIntosh; Xiuchan Guo; Yuming Zheng; Jian Liao; Hong Deng; Michael Malasky; Bailey Kessing; Cheryl A Winkler; Mary Carrington; Guy Dé The; Yi Zeng; Stephen J O'Brien
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

10.  Heterogeneity revealed through meta-analysis might link geographical differences with nasopharyngeal carcinoma incidence in Han Chinese populations.

Authors:  Wen-Hui Su; Chi-Cking Chiu; Yin Yao Shugart
Journal:  BMC Cancer       Date:  2015-08-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.